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Methods: ERV prevalence was assessed within a sample group of 441 healthy 
male and female subjects (average age: 25 years old; age ranges: 18 to 36 years old) 
using 12-lead electrocardiography. Three independent cardiologists interpreted the 
ECGs and ERV was stratifi ed according to the J-point elevation (≥0.1 mV) in the 
inferior, apicolateral or both leads associated with QRS slurring or notching. 
Results: The ERV pattern was found in 55 subjects (12.4%). A malignant ERV 
(>2 mm) was discovered in 5 subjects (0.9%). Seventeen subjects (3.8%) presented the 
ERV pattern in the lateral leads, 16 (3.6%) in the inferior leads, and 22 (5%) in both 
lateral and inferior leads. Notch pattern was present in 14 subjects (3.2%), slur pattern 
in 30 subjects (6.8%), and a combination of the two patterns in 11 subjects (2.5%). 
The ERV pattern was more prevalent in males (15.6%) than in females (11.2%). The 
ERV prevalence was not higher among the youngest subjects. None of the participants 
experienced symptoms nor had a history of familial sudden death.
Conclusion: ERV is a common fi nding among a young healthy Algerian population. 
Its prevalence seems to be more important than in highly developed countries. 
073
Amiotox registry: Predictors of amiodarone side effects
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Backround: Amiodarone is a widely used antiarrhythmic drug in Tunisia and 
worldwide. However, its side effects are quite frequent hampering its use despite 
its effi cacy.
Objective: The purpose of our study was to determin the frequency of amiodarone 
side effects and to analyse its predictors in our population.
Methods: Amiotox registery is a multicenter cross-sectional study including 
patients receiving amiodarone for more than six months regardless of the indication. 
We sought to detect the frequency and predictors of amiodarone side effects in our 
population.
Results: From May 1st 2010 to April 30th 2012, 200 consecutive patients (mean 
age: 61.9±12.9 years) were included. Mean duration of amiodarone therapy was 
51.9±48.4 months with a mean dose of 288.1±274.2 g. Atrial fi brillation was the most 
common indication. Amiodarone side effects occurred in 144 patients (72%): ocular 
(65.5%), thyroid (47.5%), cutaneous (30.5%), cardiac (35%), hepatic (16.5%) and 
neurological (14.5%) toxicity.No case of pulmonary toxicity was reported. Refering 
to multivariate analysis, independent predictors were:
• treatment duration >6 months (p=0.008) for corneal deposits.
•  age >70 years (p=0.001) and cumulative dose (p<0.001, with a logarithmic 
correlation) for thyroid toxicity.
•  age >70 years (p=0.002) and treatment duration (p<0.001, OR=1.02 for each 
added month) for cutaneous toxicity.
•  cumulative dose >300 g (p=0.016) and heart failure (p=0.05) for bradycardia.
• cumulative dose >100 g (p=0.012) for QT prolongation.
•  treatment duration (p<0.001 with a linear correlation) and betablokers concomittent 
use (p=0.046) for PR elongation.
•  treatment duration (p<0.001 with exponential correlation) and concomittent VKA 
use (p=0.018) for hepatic toxicity.
•  treatment duration >18 months (p=0.009, OR=15 with cumulatif effect) and 
concomittent CCB use (p<0.001) for neurological toxicity.
Conlusion: The results of our study confi rmed that amiodarone side effects are 
quite frequent in our population, and that in addition to treatment dose and duration, 
other predictors for these effects were identifi ed. Clinicians may be able to use 
the present results to identify patients at higher risk for amiodarone toxicity and 
implement strategies
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Objective: Electrocardiographic characteristics and abnormalities in the 
Maghrebian population haven’t yet been well described. The aim of this study was 
to evaluate the prevalence of electrocardiographic abnormalities in this population by 
screening a sample group of apparently healthy young Algerian persons.
Methods: A prospective observational study was performed using a sample 
group of 441 healthy male and female subjects (mean age 25; ranges from 18 to 36). 
All the subjects underwent a cardiac evaluation which comprised a medical history, 
a physical examination and a 12-lead electrocardiogram (ECG) at rest. The ECGs 
were analysed by three independent cardiologists.
Results: The participants were asymptomatic, with no history of sudden cardiac 
death. Their physical exam was normal. The mean HR was 75 bpm, the mean PQ, QRS 
and QTc duration was 150 ms, 78 ms and 402 ms, respectively. The mean QRS axis 
was 54°. 24 subjects (5.4%) were found with Left ventricular hypertrophy (Sokolow 
index >35 mm). First degree AV block was present in 15 patient (3.4%). 3 participants 
were found with a complete RBBB (0.6%), and 1 subject had a complete LBBB 
(0.2%). Curiously the cases of incomplete LBBB (22; 5%) were 4 times more often 
than the incomplete RBBB cases (5; 1%). A QRS axis <-30° was found in 7 patients 
and 1 patient had an axis >120°. There were no short QTc (<320 ms). 7 (1.6%) cases 
of long QTc (>460 ms) were discovered.
Conclusion: In our study, 76 patients, meaning 17.2% of the participants were 
found with an ECG abnormality but without presenting any symptoms or abnormalities 
at the clinical examination. These data suggest that guidelines for the ECGs analysis 
should be adjusted to the target population.
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Background: Early repolarization variant (ERV) is considered to be a benign 
condition, but recently its presence has been related with a certain vulnerability to 
ventricular fi brillation in many case reports and case-control studies. The ERV was the 
subject of many studies in highly developed countries and its prevalence is estimated 
between 3.3 and 6.7%. ERV prevalence in the Maghrebian population is unknown. 
The aim of this study was to appreciate the prevalence of the ERV within a sample 
group of healthy Algerian young adults. 
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Materials and Methods: ten patients of afrio caribbean were hospitalized for 
acute atrioventricular block and followed at least 1 month.Six male and four female 
has a diagnosis od SCD using Hb electrophoresis received regulary labotary, Chest 
ray and physical evaluation completed with EKG and echocardiography and a chronic 
transfusion therapy for primary stroke prevention requires careful surveillance for 
iron overload and chelation therapy; all the patients used daily antibiotic until fi ve 
years and annual infl uenzae and pneumococcal vaccination. Blood samples with Hb 
electrophoresis, blood counts, Emmel test on blood fi lm, bacteriology and room air 
arterial gas sampling was performed in all patients.
Results: the most common presenting symptoms were asthenia, bradycardia under 
35 ppm with mid cardiac attack, cough fever, one acute chest syndrom, shortness of 
breath, no heart failure or valvular endocarditis.The frequency of symptom was not 
age dependant between Hb SS or Hb SC.Four patients had a type 2 atrioventricular 
block with thin QRS, six patients with a completed atrioventricular block, no indication 
of cardiac pacing was done. Laboratory fi ndings documented during hospitalization 
showed a signifi cant change with hemoglobin dropping an average of 7 g/dl and an 
increasing of withe blood cell also during ACS (one patient). No bacteremia was 
documented and the seasonal variation was observed in winter, young patients was 
most striking with an increased rate into the winter. Echocardiography was performed 
with a mild left ventricular dilatation overload, a preserved LVEF, a mild left atrial 
dilatation, no pericardial effusion and no arterial pulmonary hypertension or endocarditis.
SCD was once thought to involve solely the polymerisation of Hb S, vasoocclusion 
involves leucocytes and altered nitric oxyd metabolism, hypercoagubility provided 
understanding of the physiopathology of this disease had led to new opportunities 
to improve patient care.
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Introduction: Power spectral analysis of heart rate variability is a tool known 
to provide information of interest on the autonomic control of heart rate in human. 
However, its use and its conditions of application and interpretation are not well 
defi ned for cardiovascular safety pharmacology studies. Likewise, data of power 
spectral analysis of heart rate variability in cynomolgus monkeys are not available. 
This study was designed to evaluate the relevance of this biomarker in this non human 
primate species, and to compare results with those from beagle dogs.
Methods: Power spectral analysis of heart rate variability was performed on 
data collected in both species by telemetry. Various pharmacological agents were 
tested in order to compare the profi le of responses in both species after modifying 
the autonomic nervous balance.
Results: Heart rate variability in the cynomolgus monkey is mainly driven by the 
parasympathetic nervous system as in beagle dogs although vagal tone is less than in 
dogs. Power spectral analysis of heart rate variability allows detection of interaction 
with the autonomic nervous system in both species in all investigated situations, 
i.e. sympatholytic/sympathomimetic and parasympatholytic/parasympathomimetic 
drug induced effects. However, due to species difference in the autonomic control of 
heart rate, cynomolgus monkeys are likely to be more sensitive than beagle dogs for 
assessment of sympatholytic properties.
Discussion: This study confi rms that power spectral analysis of heart rate variability 
from data derived from ECG recordings in telemetry studies is applicable for detection 
of interaction with the autonomic nervous system and may provide in either species 
relevant information for interpretation of electrocardiographic changes, in particular 
on ventricular repolarisation, induced by new drug entities under evaluation. However, 
interspecies differences in autonomic control must be taken into account when 
interpreting possible drug effects.
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Background: Systemic calcifi cations are a common fi nding in chronic renal 
disease. However, cardiac involvement is especially ominous and leads to conduction 
defects and arrhythmia that may cause sudden death. 
Patients and Methods: Prospective study screening 52 hemodialysis patients for 
cardiac arrhythmia using ECG and 24 h Holter-ECG monitoring including hemodialysis 
sessions. Patients with symptomatic atrioventricular block (AVB) were treated by 
permanent pacing and underwent echocardiography and 64-slice spiral cardiac CT 
scanner (CCTS) to assess the presence and localisations of cardiac calcifi cations, and 
to determine Agatson coronary calcium-scoring (ACCS). 
Results: Atrioventricular block was found in 4 patients (7.7%): 4 men, mean aged 
61 years with a mean hemodialysis duration of 83.25 months. Two patients were diabetic 
and hypertensive and one had ischemic cardiomyopathy history. Clinical symptoms 
were especially fatigue and unconsciousness. One case of reversible cardiopulmonary 
arrest was noted. ECG and Holter-ECG revealed complete atrioventricular block in 
all cases. Mitral valve calcifi cations were present in 2 patients, 2 subjects had aortic 
valve calcifi cations and left ventricular hypertrophy. Systolic function was normal 
in 3 cases. CCTS demonstrates a high ACCS (>401) in two cases with a special 
involvement of anterior interventricular artery. No short or long-term complications 
related to pacemaker implantation were encountered.
Conclusion: Cardiovascular calcifi cations are associated with several disturbances 
of the conduction system in maintenance hemodialysis, and leads to substantial 
morbidity and mortality. Many risk factors are established such as advanced age and 
duration of dialysis. In Our patients, AVB was additionally attributed to metastatic 
calcifi cations involving the cardiac valves and the coronary arteries consecutive to 
long-term exposure to imbalances in mineral metabolism and the use of calcium 
carbonate as phosphate binder and vitamin D to treat secondary hyperparathyroidism. 
More attention should be focused on screening of conduction defects by Holter ECG 
in earlier chronic renal disease to avoid consequent mortality.
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Acute atrioventricular block in african or caribbean patients consider 
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We report ten rares cardiac complications of sickle cell anemia in blacks patients 
which was an acute paroxysmal atrioventricular block.Six male and four female w 
ith a average age of 39 +- 4 years, had an heterozygous genotype (three patients) or 
homozygous in six patients (SS/SC) one patient had a heterozygous genotype with 
a βthalassémia were observed for a acute paroxysmal atrioventricular block.
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atrial premature contractions were uniformLy distributed in the different periods of 
the Holter (p=0.01, Spearman correlation). 13.5% of CKD (which 40% only during 
the HD, 20% during the HD and the late-HD, 20% during the early and the late-HD 
and 20% only during the late-HD) and 3.12% of C displayed atrial fi brillation (AF) 
(p=0.2). Ventricular premature contractions (VPC) were frequent (81% in CKD vs 
77% in C, p=0.48). Ventricular tachycardia was observed in 5% of CKD (which 100% 
in the HD) vs 6% of C, p=0.64. Only CKD developed torsade de pointes (3% of CKD 
during the late-HD period). Polymorphic VPC were described in 32% of CKD and 
3% of C, p=0.002. These polymorphic VPC were equally distributed in each period 
of the Holter (p=0.01, Spearman correlation). A fallen SDNN less than 80 msec was 
found in 54% of CKD vs 26% of C, p=0.036). There was not correlation between AF 
(p=0.64), ventricular arrhythmia (p=0.40) and low SDNN in our study. 
Conclusions: CKD developed as many atrial and ventricular arrhythmia as high 
cardiovascular comorbidity C except for torsade de pointes and polymorphic VPC. This 
difference would be explained by uremic myocardial fi brosis. Dialysis could provoke 
arrhythmia because of fast hydro electrolyte shifts. Cardiac autonomic functions were 
signifi cantly altered in CKD, which is related with an increased risk of sudden death.
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Background: Flecainide (F) and ajmaline (A) challenges are used to unmask 
the aspect of Brugada syndrome. There is no direct comparison of these two drugs 
in the large population of patients
Methods: Injections are performed by continuous infusion over a period of 10 
minutes at 1mg/kg dose for A and 2 mg/kg for F.
Results: F was performed in 412 patients and A in 311.
Mean age was 41±16 years and 42 F±16 years in A (p=0.2) and there was 194 
women in group F (47%) vs 152 in group A (48%), NS. All patients were in sinus 
rhythm in both groups. There was no difference between the two groups for heart rate 
70±12 vs 71±13 bpm (p=0.17), PR 161±28 msvs 162±29 ms (p=0.63), QRS 95±20 
msvs 96±13 ms (p=0.94). The QTc appears to be longer in the F than in the A group 
409±29 vs 418±28 ms (p<0.001).
During the test, HR increase in both groups 74±12 vs 78±12 bpm but the increase 
was more pronounce in A (p<0.001). There was no difference for PR 190±33 msvs 
187±36 ms (p=0.4) and QRS 114±20 msvs 115±23 ms (p=0.35). The QTc remains 
longer in the A than in the F group 451±33 vs 438±34 ms (p<0.001).
The number of positive tests F 123/412 (30%) vs 121/311 (39%) was slightly 
higher in A group even if this difference was not signifi cant.
During the tests arrhythmic complications were rare (VPBs 5 vs 2 and VT 1 vs 3).
Conclusion: In this large population of patients, the results of Flecainide and 
Ajmaline challenge are similar for conduction parameters and risk of ventricular 
arrhythmias.
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Introduction: Joining the french military forces requires a physical examination 
and an ECG. This function is devolved to military general practionners. The quality 
of their ECG interpretation has been assessed in a professional practice audit (PPA). 
Materials and Methods: From September 2009 to April 2010 we lead a prospective 
study in four military units. The aim was to compare the ECG reading of military GPs 
with cardiologists. Interpretations were randomized and standardized. 
Results: 1183 ECGs were included, from a population of 32 years average age, 
predominantly male (90%). 293 had one or more atypical pattern, the most common 
being the early repolarization (196, or 16.6% of ECG). 25 showed an abnormality 
requiring cardiologist’s advice. The overall concordance rate between the interpretation 
of military GP and the cardiologist was 72%. Detecting abnormalities in medical unit 
was incomplete with a sensitivity of 33%, a specifi city of 99%. The positive predictive 
value of requests for cardiologist’s advice prescribed by the military physician was 64%. 
Conclusion: ECG reading by military GPs is usefull and suffi cient in most of 
cases. To improve and securise our practice it is necessary to strenghten the link 
between GPs and cardiologists. Tools such as the establishment of a reading grid, 
using a telemedicine network, as well as education and ECG training may be ways 
to improve this interpretation.
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Introduction and Aims: Sudden cardiac death (SCD) is the leading cause of death 
among chronic hemodialysis patients (CKD). The aim of our study was to determine 
in which degree the dialysis is implicated in arrhythmias development in CKD. 
Methods: Continuous 24-hour Holter monitoring were carried out in 37 CKD 
and in a control group (C) composed by 32 patients with cardiovascular morbidity but 
without renal failure. We studied atrial and ventricular arrhythmia in several times: the 
dialysis session (HD), 4-hour post dialysis period (early-HD) and the next 16 hours 
(late-HD). Temporal parameter (Standard Deviation of the NN intervals SDNN) of 
heart rate variability was calculated from these recordings.
Results: The included patients had cardiovascular morbidity (HTA in 91.9 of CKD 
vs 100% of C, p=0.15; left ventricular hypertrophy in 73 vs 68.8%, p=0.4; diabetes 
in 37.8 vs 18.8%, p=0.07, hypercholesterolemia in 67.6 vs 75%, p=0.3). Ectopic 
